Meet the team

Who We Are

New Equilibrium brings together interdisciplinary experts with the shared goal of drugging intrinsically disordered proteins.

Internal Team

Virginia Burger, Ph.D.
Co–founder and CEO

Soumya Ray, Ph.D.
Interim CTO

Peter Tompa, Ph.D.
Co–founder and Chair of SAB

Charles DeLisle, Ph.D.
Principal Scientist, Biophysics

Hsiao-Yun Chen, Ph.D.
Principal Scientist, Biochemistry & Cell Biology

Lars Bratholm, Ph.D.
Principal Scientist, Machine Learning

Tao Jiang, Ph.D.
Principal Scientist, Computational Chemistry

Acadia Connor, B.A.
Research Associate II and Manager, MD Hardware

Bentley Wingert, Ph.D.
Scientist I, Computational Chemistry

Hang Cao, B.F.A.
Communications Manager and DEI Coordinator

Austin Alexander, B.S.
Operations Manager

Scientific Advisory Board

VK Gadi, M.D. PH.D.
Professor and Director, Medical Oncology, U of Illinois at Chicago

Lila M. Gierasch, Ph.D.
 Professor, Chemistry & Biochemistry and Molecular Biology, UMass Amherst

Emir Roach, M.D.
Principal, Biopharma, Boston Consulting Group

Sally Wang Liang, J.D./M.P.H.
VP of Business Development, Head of Global Business Unit, PepLib

Olexandr Isayev, Ph.D.
Professor, Department of Chemistry, Carnegie Mellon University

Keith Dunker, Ph.D.
 Professor Emeritus of Biochemistry and Molecular Biology, Indiana University

Zsuzsanna Dosztányi, Ph.D.
Professor, Biochemistry, Eötvös Loránd University